NCT06700785已完成不适用
A Pharmacokinetic Comparison of Three Butyrate Products
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- plasma butyrate levels
研究概览
简要总结
This study is a randomized, three-arm, interventional study of N=10 apparently healthy men. This study will quantify plasma butyrate responses to a single dose of three different butyrate products.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 25 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Provide voluntary signed and dated informed consent.
- •Be in good health as determined by medical history and routine blood chemistries.
- •Age between the ages of 25 and 45 (inclusive).
- •Body Mass Index of 18.5-24.9 (inclusive).
- •Body weight of at least 110 pounds.
- •Normotensive (seated, resting systolic blood pressure <140 mm Hg and diastolic blood pressure < 90 mm Hg. If the first measurement is slightly elevated above these limits, the subject will be given a brief (5-minute) rest period, and two more measurements will be taken. The average of all three measurements will be used to determine eligibility.
- •Normal seated, resting heart rate (<90 per minute).
- •Willing to duplicate their previous 24-hour diet, refrain from alcohol, caffeine, and exercise for 24 hours and fast for 10 hours prior to each of the treatments.
- •Participant agrees to maintain existing dietary and physical activity patterns throughout the study period.
- •Participant is willing and able to comply with the study protocol.
排除标准
- •A history of unstable or new-onset cardiovascular/cardiorespiratory, liver, or renal disease.
- •The participant's alcohol consumption is more than two standard alcoholic drinks per day or more than 10 drinks per week or has a history of drug/alcohol abuse or dependence.
- •History of diabetes (any form) or any endocrine disorder.
- •Fasting blood sugar of > 125 mg/dL.
- •Current smokers or smoking cessation within the past month (28 days).
- •History of hyperparathyroidism or an untreated thyroid disease.
- •History of malignancy in the previous five years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin).
- •Any history of gastrointestinal bypass surgery, etc., or any known functional gastrointestinal disorder that may impact nutrient absorption, e.g., short bowel syndrome, atrophic gastritis, IBD, diarrheal illnesses, history of colon resection, gastroparesis, gastric resection, celiac disease, or Inherited Errors of Metabolism (such as PKU).
- •Chronic inflammatory condition or disease (e.g., rheumatoid arthritis, Crohn's Disease, ulcerative colitis, lupus, HIV/AIDS, etc.).
- •History of using butyrate or tributyrin-containing dietary supplements within the past seven days.
- •Known allergy or sensitivity to any ingredient in the test formulations as listed on the product label.
- •Any other diseases or conditions that, in the opinion of the medical staff, could confound the primary endpoints or place the subject at increased risk of harm if they were to participate.
结局指标
主要结局
plasma butyrate levels
时间窗: Prior to product administration (time 0), as well as 20, 45, 90, 150, and 210 minutes post-dose
Plasma butyrate levels in ug/mL.
次要结局
- Visual analog scales for cognitive function.(0, 20, 45, 90, 150 and 210 minutes post-dose)
- Visual analog scales for mood.(0, 20, 45, 90, 150 and 210 minutes post-dose)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated SymptomsGut HealthNCT06419231Supplement Formulators, Inc.143
已完成
不适用
Butyrate: effect of oral administration in patients with mild hypertensiohigh blood pressure10057166hypertensionNL-OMON49499Academisch Medisch Centrum50
已完成
不适用
Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic SyndromeNAFLDMetabolic SyndromeNCT06398522University of Bologna50
招募中
不适用
Butyrate: Effect of Oral Administration in patients with Mild HypertensiohypertensionNL-OMON22936Amsterdam UMC50
招募中
3 期
Butyrate supplements improve efficacy in patients with moderate to severe chronic spontaneous urticaria, A randomized, double-blind, placebo-controlled trialchronic urticariabutyrateUAS7TCTR20220302003Department of Medicine of Phramongkutklao hospital40